Global /United States /Healthcare /Medical Devices /TMCI
chevron_leftBack
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI
NASDAQ: TMCI Delayed
1.77USD -7.3%
As of 13 June 2026, Treace Medical Concepts, Inc. has a market cap of $114.38M USD, ranking #24600 globally and #3818 in the United States. It ranks #2197 in the Healthcare sector, and #452 in the Medical Devices industry.
Global Rank
24600
Country Rank
3818
Sector Rank
2197
Industry Rank
452
Key Stats
Market Cap
$114.38MUSD
Enterprise Value
$136.9MUSD
Revenue (TTM)
$212.69MUSD
EBITDA (TTM)
-$44.53MUSD
Net Income (TTM)
-$59.0MUSD
EBITDA Margin
-21%
Profit Margin
-28%
PS Ratio
0.5
PB Ratio
1.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
John Treace open_in_new
Employees
450
Founded
2014
IPO
23 Apr 2021
Website
treace.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-7.3% -4.4% 43% -27% -74% -75%

News

Loading...

TMCI Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
TMCI
Treace Medical Concepts Inc
ISIN: US89455T1097
Shares Out.:
64.873M1 Shares Float: 48.155M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
1.77 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
151K%
25.8
$160.73B
140K%
56.7
$159.07B
139K%
25.6
DHR
$126.55B
111K%
34.7
SYK
$120.69B
105K%
38.3
$84.93B
74K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
89K%
22.2
$97.46B
84.32B EUR
85K%
36.7
7741
$61.41B
9.83T JPY
54K%
40.0
$45.47B
39.34B EUR
40K%
18.7
ALC
$36.38B
28.99B CHF
32K%
37.9
$30.06B
203.66B CNY
26K%
26.0
chevron_leftBack